Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
7.35
+0.01 (0.14%)
At close: Nov 19, 2026, 4:00 PM EST
7.41
+0.06 (0.82%)
After-hours: Nov 19, 2026, 7:56 PM EST
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $675.31 million as of November 19, 2026. It is the 11,894th most valuable company in the world and the 2,443rd biggest in the United States. Its market cap has decreased by 29.96% in one year.
Market Cap
675.31M
Enterprise Value
209.04M
1-Year Change
-29.96%
Global Rank
Country Rank
#2,443 United States
Category
ChartMarket Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $675.31M, an increase of 493.94%. That is a compound annual growth rate of 17.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 675.31M | -25.31% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 726.44M |
| Solid Biosciences | 718.77M |
| Apnimed | 717.92M |
| Attovia Therapeutics | 712.20M |
| Sagimet Biosciences | 686.56M |
| Prime Medicine | 685.24M |
| Nuvectis Pharma | 682.28M |
| Iambic Therapeutics | 675.94M |